Company / R&D per Share
AXIM BIOTECHNOLOGIES, INC. R&D per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.00
FY2023
5-year range
$0.00 / $0.04
FY2019-FY2023
Trend
-41.4%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.04 to $0.00 over the past 5 years.
Based on SEC 10-K filings.
0.00 in FY2023 with a 5-year CAGR of -55.6%.
Declined from $0.04 to $0.00 over the past 5 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -55.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, r&d per share decreased 41.4% year-over-year.
- Peak r&d per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $0.00 | -41.4% |
| FY2022 | $0.00 | -97.0% |
| FY2018 | $0.04 | +46.2% |
| FY2017 | $0.03 | +333.5% |
| FY2016 | $0.01 | -65.7% |
| FY2015 | $0.02 | - |
| FY2013 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026